Silo Pharma, Inc. announced that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price requirement of $1.00 per share. The company's closing bid price was at or above $1.00 from June 3, 2026, through June 16, 2026, resolving the compliance issue. Silo Pharma, Inc. is a pharmaceutical company focused on developing and commercializing specialized drug delivery technologies and specialized drug products.
